Approval · Notice of Compliance 28213 · 2022
LOSEC: Notice of Compliance 28213
Issued May 18, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28213
- Date
- May 18, 2022
- Company
- Cheplapharm Arzneimittel GmbhGreifswald, Mecklenburg - West Pomerania, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates in response to an Advisement Letter, and update the Product Monograph to the 2020 Master Template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOSEC | Not yet assigned | — |
Medicinal ingredients
- OMEPRAZOLE 20 MG per CAP